UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
British journal of pharmacology, ISSN 0007-1188, 11/2007, Volume 152, Issue 5, pp. 567 - 575
CB2 | CB1 | GPR119 | cannabinoid | non‐CB1/CB2 | GPR55 | Cannabinoid | Non-CB | CB | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cannabinoid Receptor Agonists | Animals | Humans | Receptors, Cannabinoid - physiology | Receptors, G-Protein-Coupled - genetics | Phylogeny | Receptors, G-Protein-Coupled - agonists | Receptors, Cannabinoid - genetics | Cannabinoids - pharmacology | Receptors, G-Protein-Coupled - physiology | Index Medicus | Reviews | non-CB1
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
European journal of pharmacology, ISSN 0014-2999, 10/2017, Volume 813, pp. 66 - 83
Receptor heteromerization | CB1 | SRET2 | BRET2 | G protein coupling | D2L | BRET | SRET | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | GTP-Binding Protein alpha Subunits - metabolism | Humans | Receptors, Dopamine D2 - agonists | beta-Arrestin 1 - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Receptors, Dopamine D2 - metabolism | Arachidonic Acids - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB1 - agonists | Signal Transduction - drug effects | Allosteric Site | HEK293 Cells | Protein Structure, Quaternary | Receptors, Dopamine D2 - chemistry | Receptor, Cannabinoid, CB1 - chemistry | Quinpirole - pharmacology | Phosphorylation - drug effects | Protein Multimerization - drug effects | Proteins | Phenols | Cyclic adenylic acid | G proteins | Index Medicus
Journal Article
2006, Methods in molecular medicine, ISBN 9781588293503, Volume 123, xv, 306
Book
Pharmacological reviews, ISSN 0031-6997, 09/2011, Volume 63, Issue 3, pp. 461 - 470
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cannabinoid Receptor Modulators - metabolism | Receptor, Cannabinoid, CB2 - agonists | Cannabinoid Receptor Antagonists | Cannabinoids - antagonists & inhibitors | Humans | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Molecular Targeted Therapy | Receptor, Cannabinoid, CB2 - genetics | Receptors, Cannabinoid - metabolism | Receptor, Cannabinoid, CB1 - agonists | Neurons - metabolism | Neurons - drug effects | Receptors, Cannabinoid - genetics | Nerve Tissue Proteins - antagonists & inhibitors | Nerve Tissue Proteins - agonists | Cannabinoid Receptor Modulators - agonists | Nerve Tissue Proteins - genetics | Cannabinoids - pharmacology | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Cannabinoid Receptor Agonists | Animals | Receptor, Cannabinoid, CB1 - genetics | Cannabinoid Receptor Modulators - antagonists & inhibitors | Cannabinoids - agonists | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Index Medicus
Journal Article
Nature neuroscience, ISSN 1097-6256, 09/2011, Volume 14, Issue 9, pp. 1160 - 1168
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Rotarod Performance Test - methods | Receptor, Cannabinoid, CB2 - agonists | Cannabinoids - administration & dosage | Mice, Inbred C57BL | Motor Activity - drug effects | Male | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Administration, Intranasal | Indoles - administration & dosage | Dopamine Uptake Inhibitors - administration & dosage | Mice, Knockout | Brain - drug effects | Brain - metabolism | Cocaine - administration & dosage | Receptor, Cannabinoid, CB2 - metabolism | Self Administration | Animals | Microdialysis | Analysis of Variance | Conditioning, Operant - drug effects | Mice | Receptor, Cannabinoid, CB1 - deficiency | Receptor, Cannabinoid, CB2 - deficiency | Index Medicus
Journal Article
Biochemical journal, ISSN 0264-6021, 09/2015, Volume 470, Issue 2, pp. 181 - 193
Orphan nuclear receptor | GSK5182 | Bile acid | Oestrogen-related receptor γ (ERRγ ) | Cholesterol 7α-hydroxylase (CYP7A1) | Cannabinoid receptors | Small heterodimer partner (SHP) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Promoter Regions, Genetic | Gene Expression | Receptors, Estrogen - metabolism | Receptors, Estrogen - genetics | Humans | Liver - metabolism | Mice, Inbred C57BL | Cells, Cultured | Bile Acids and Salts - metabolism | Hepatocytes - metabolism | Rats, Sprague-Dawley | Mice, Knockout | Cholesterol 7-alpha-Hydroxylase - genetics | Receptor, Cannabinoid, CB1 - metabolism | Ethanol - pharmacology | Glycerides - pharmacology | Animals | Receptor, Cannabinoid, CB1 - agonists | Receptor, Cannabinoid, CB1 - genetics | Drug Inverse Agonism | HEK293 Cells | Cholesterol 7-alpha-Hydroxylase - biosynthesis | Transcription, Genetic | Receptors, Cytoplasmic and Nuclear - metabolism | Index Medicus | bile acid | cholesterol 7α-hydroxylase (CYP7A1) | small heterodimer partner (SHP) | cannabinoid receptors | orphan nuclear receptor | oestrogen-related receptor γ (ERRγ)
Journal Article
Synapse (New York, N.Y.), ISSN 0887-4476, 03/2013, Volume 67, Issue 3, pp. 145 - 159
5‐HT receptor | cannabinoid receptors | G protein coupled receptor | prefrontal cortex | ERK | 5-HT receptor | Prefrontal cortex | Cannabinoid receptors | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Transcription, Genetic - drug effects | Up-Regulation | Receptor, Serotonin, 5-HT2A - genetics | Rats | Male | Extracellular Signal-Regulated MAP Kinases - metabolism | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Rats, Sprague-Dawley | RNA, Messenger - biosynthesis | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | MAP Kinase Signaling System - drug effects | Receptor, Cannabinoid, CB1 - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Cyclohexanols - pharmacology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Receptor, Serotonin, 5-HT2A - metabolism | Mitogen-Activated Protein Kinase 1 - metabolism | Physiological aspects | Phenols | Messenger RNA | G proteins | Serotonin | Depression, Mental | Index Medicus | ERK MAPK
Journal Article